Most Recent
The Daily Mail has argued that Nine sports presenter Erin Molan should be stripped of a $150,000 defamation damages award because of her history of “seriously egregious conduct” on 2GB’s Continuous Call Team radio show.
Extended settlement talks in a Fair Work suit brought by the chief of staff to Independent MP Monique Ryan have failed, and lawyers for Sally Rugg will seek to add claims of serious contraventions to what they say is a test case for determining 'reasonable' overtime.
S&P Global is fighting bids to expand a class action alleging systemic defects in its ratings systems to a new type of complex financial product and to include allegations from a US Department of Justice case in a separate suit by two Cayman Islands-based companies.
Casino giant Crown has admitted to a "significant number" of anti-money laundering and counter terrorism breaches in a case brought by AUSTRAC.
Boost Mobile has sued telecommunications giant Singtel Optus, alleging it “misappropriated” its goodwill by marketing services under a similar product name after Boost chose to move its mobile network to Telstra.
The divisive issue of whether judges are empowered to make a common fund order to distribute the costs of a funding commission at the settlement stage of a class action is headed back to the Full Federal Court next week.
A law firm has questioned an “innovative” funding model proposed by its rival in a contest to run a class action against Jaguar Land Rover over allegedly defective diesel filters in its vehicles.
A judge has indicated his willingness to approve a $25 million settlement in a class action against dairy co-op Fonterra, but deferred the question of the funder's cut until after the Full Court rules on whether the court has the power to make a common fund order at settlement.
Advanta Seeds has won an appeal upholding the dismissal of a class action by sorghum farmers over allegedly contaminated seeds, with a court finding that the seed producer’s duty of care was negated by clear disclaimers.
A class action against Bayer over its Essure device has won court approval to add new allegations, including that the contraceptive caused sexual dysfunction, with a judge finding the new claims could not have taken the German drug maker by surprise.